ArticleDiagnostics (Basel, Switzerland)2023

Efficacy and Safety of Nintedanib in Patients with Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD): A Real-World Single Center Experience.

Maria Boutel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.